These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1102 related items for PubMed ID: 21341156

  • 1. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C, Yetkin F, Görgeç S, Ersoy Y.
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [Abstract] [Full Text] [Related]

  • 2. Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
    Mody RM, Erwin DP, Summers AM, Carrero HA, Selby EB, Ewell AJ, Moran KA.
    Ann Clin Microbiol Antimicrob; 2007 Jun 06; 6():6. PubMed ID: 17553151
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
    Kiremitci A, Dinleyici EC, Erben N, Durmaz G, Yargic ZA, Aybey AD, Usluer G.
    Expert Opin Pharmacother; 2008 Jun 06; 9(9):1441-9. PubMed ID: 18518776
    [Abstract] [Full Text] [Related]

  • 4. Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
    Johnson JK, Robinson GL, Pineles LL, Ajao AO, Zhao L, Albrecht JS, Harris AD, Thom KA, Furuno JP.
    Antimicrob Agents Chemother; 2017 Apr 06; 61(4):. PubMed ID: 28167543
    [Abstract] [Full Text] [Related]

  • 5. Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems.
    Vading M, Samuelsen Ø, Haldorsen B, Sundsfjord AS, Giske CG.
    Clin Microbiol Infect; 2011 May 06; 17(5):668-74. PubMed ID: 20649801
    [Abstract] [Full Text] [Related]

  • 6. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
    Eser OK, Altun Uludağ H, Ergin A, Boral B, Sener B, Hasçelik G.
    Mikrobiyol Bul; 2014 Jan 06; 48(1):59-69. PubMed ID: 24506716
    [Abstract] [Full Text] [Related]

  • 7. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
    Çakar A, Akyön Y, Gür D, Karatuna O, Öğünç D, Özhak Baysan B, Çöplü N, Çağatay M, Kılıç A, Baysallar M, Bakıcı Z, Çelik C, Gülay Z, Aydemir Ş, Tünger A, Kılıç H, Erçal BD, Aşçı Toraman Z, Zer Y, Büyüktaş A, Ay S, Aktaş Z, Kayacan Ç, Bayramoğlu G, Aydın F, Dündar D, Hasdemir U, Ayaş R, Yanık K, Günaydın M, Güdücüoğlu H, Parlak M.
    Mikrobiyol Bul; 2016 Jan 06; 50(1):21-33. PubMed ID: 27058326
    [Abstract] [Full Text] [Related]

  • 8. Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi.
    Taneja J, Mishra B, Thakur A, Dogra V, Loomba P.
    J Infect Dev Ctries; 2010 Sep 03; 4(8):517-20. PubMed ID: 20818104
    [Abstract] [Full Text] [Related]

  • 9. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P, Metan G, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2007 Oct 03; 41(4):579-84. PubMed ID: 18173077
    [Abstract] [Full Text] [Related]

  • 10. Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
    Jean SS, Lee WS, Bai KJ, Yu KW, Hsu CW, Yu KW, Liao CH, Chang FY, Ko WC, Wu JJ, Chen YH, Chen YS, Liu JW, Lu MC, Liu CY, Chen RJ, Hsueh PR.
    Diagn Microbiol Infect Dis; 2015 Apr 03; 81(4):290-5. PubMed ID: 25600841
    [Abstract] [Full Text] [Related]

  • 11. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Moczygemba LR, Frei CR, Burgess DS.
    Clin Ther; 2004 Nov 03; 26(11):1800-7. PubMed ID: 15639692
    [Abstract] [Full Text] [Related]

  • 12. [Carbapenem resistance in Klebsiella pneumoniae clinical isolates from urinary tract infections].
    Mereuţă AI, Enache EM, Dumitraşcu A, Vremeră T, Coman G.
    Rev Med Chir Soc Med Nat Iasi; 2011 Nov 03; 115(2):531-5. PubMed ID: 21870752
    [Abstract] [Full Text] [Related]

  • 13. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    Zhang H, Yang Q, Liao K, Ni Y, Yu Y, Hu B, Sun Z, Huang W, Wang Y, Wu A, Feng X, Luo Y, Chu Y, Chen S, Cao B, Su J, Duan Q, Zhang S, Shao H, Kong H, Gui B, Hu Z, Badal R, Xu Y.
    BMC Infect Dis; 2017 Dec 18; 17(1):776. PubMed ID: 29254478
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.
    Kader AA, Kumar A.
    Ann Saudi Med; 2005 Dec 18; 25(3):239-42. PubMed ID: 16119526
    [Abstract] [Full Text] [Related]

  • 15. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal.
    Nepal K, Pant ND, Neupane B, Belbase A, Baidhya R, Shrestha RK, Lekhak B, Bhatta DR, Jha B.
    Ann Clin Microbiol Antimicrob; 2017 Sep 19; 16(1):62. PubMed ID: 28927454
    [Abstract] [Full Text] [Related]

  • 16. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles].
    Oksüz L, Gürler N.
    Mikrobiyol Bul; 2009 Apr 19; 43(2):183-94. PubMed ID: 19621602
    [Abstract] [Full Text] [Related]

  • 17. Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.
    DeRyke CA, Banevicius MA, Fan HW, Nicolau DP.
    Antimicrob Agents Chemother; 2007 Apr 19; 51(4):1481-6. PubMed ID: 17283197
    [Abstract] [Full Text] [Related]

  • 18. [In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase].
    Villar HE, Jugo MB, Visser M, Hidalgo M, Hidalgo G, Maccallini GC.
    Rev Esp Quimioter; 2014 Mar 19; 27(1):51-5. PubMed ID: 24676243
    [Abstract] [Full Text] [Related]

  • 19. Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.
    Raveh D, Yinnon AM, Broide E, Rudensky B.
    Chemotherapy; 2007 Mar 19; 53(3):185-9. PubMed ID: 17347564
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Bishara J, Livne G, Ashkenazi S, Levy I, Pitlik S, Ofir O, Lev B, Samra Z.
    Isr Med Assoc J; 2005 May 19; 7(5):298-301. PubMed ID: 15909461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.